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Abstract The effect of exogenous Fe-citrate complex (Fe doses
of 120 and 240 Wmol/kg) on nitric oxide (NO) production in vivo
has been studied in blood and liver tissue of endotoxin-treated
mice. Fe-citrate complex was administered to mice subcuta-
neously at the same time with intravenous injection of
Escherichia coli lipopolysaccharide (LPS). Iron-dependent de-
crease in NO32 =NO
3
3 and nitrosyl hemoglobin levels in blood of
animals was detected at 6 h after LPS administration, suggesting
systemic attenuation of NO generation. NO production in the
liver tissue of LPS-treated mice was decreased after Fe
administration judging from the amount of mononitrosyl-iron
complexes formed in the tissue by diethyldithiocarbamate. The
iNOS protein determination in the liver tissue of LPS-treated
mice demonstrated iron-dependent inhibition of iNOS expres-
sion. We have found previously that exogenous iron does not
affect systemic NO level when it is given at 6 h after LPS
injection, i.e. after iNOS expression. This is a first report
demonstrating iron-dependent iNOS down-regulation in endo-
toxin-treated mice.
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1. Introduction
The early studies on interaction between iron and infections
yielded controversial results. Iron supports bacterial growth
[1], but it can inactivate bacterial exotoxins and endotoxin [2].
It has been recently established that these bacterial products
trigger harmful overproduction of nitric oxide (NO) leading to
cardiovascular collapse, multiple organ failure and death [3].
Cardiovascular response to endotoxin and animal survival
improved in mice lacking iNOS enzyme, which generates
NO during infection [4,5]. Intracellular iron is a major target
of endogenous NO, which alters the activity of iron-dependent
enzymes [6]. Nitric oxide controls free iron level in cells by
activating iron regulatory factor [7] and a¡ecting enzymes
involved in heme metabolism [8]. Weiss et al. [9] have pro-
posed feedback regulation between iron metabolism and NOS
pathway, based on iron control of nuclear transcription for
iNOS in macrophages in vitro. However, in vivo interaction
between NO pathway and iron may be more complicated
since macrophages and other iNOS-expressing cells are sub-
jected to a complex activation and suppression by cytokines,
reactive oxygen species (ROS) and nitric oxide. In addition,
the traditional view of the iron as a prooxidant and proin-
£ammatory factor [10] suggests Fe-induced ROS production
leads to activation of nuclear transcription factor NF-UB and
subsequent iNOS expression in tissue. Holotransferrin (difer-
ric transferrin), for example, has been reported to induce
iNOS mRNA expression in rat cultured aortic smooth muscle
cells [11]. In this study we have examined the e¡ect of exog-
enous Fe-citrate complex on the level of nitric oxide in blood
and tissue as well as iNOS expression in the liver of endotox-
in-treated mice. Our results demonstrate that exogenous iron
attenuates nitric oxide production in vivo in endotoxin-treated
mice via down-regulation of iNOS expression.
2. Materials and methods
2.1. Materials
ICR mice (female, 30^35 g) were supplied by Harlan Sprague-Daw-
ley (Indianapolis, IN). All animal experiments were guided by the
principles for the care and use of laboratory animals as recommended
by the US Department of Health and Human Services, and approved
by the George Washington University Animal Care and Use Commit-
tee. Lipopolysaccharide (LPS, Escherichia coli O26:B6) and desferrox-
amine mesylate were from Sigma (St. Louis, MO). Diethyldithiocar-
bamate (DETC) was purchased from Aldrich (Milwaukee, WI), 3-
morpholinosydnonimine (SIN-1) was from Cayman Chemical Com-
pany (Ann Arbor, MI). Polyclonal rabbit anti-iNOS antibody was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and
horseradish peroxidase (HRP) chemiluminescent substrate Supersignal
was from Pierce (Rockford, IL). Other chemicals and reagents were
purchased from Sigma (St. Louis, MO). NO32 was measured by the
Griess colorimetric assay [12]. NO33 was ¢rst converted to NO
3
2 by E.
coli nitrate reductase [13] and measured as described above.
2.2. Animal procedure
LPS (6 mg per mouse) was given via the tail vein and at the same
time iron-citrate complex (33 mg/kg FeSO4W7H2O plus 167 mg/kg of
sodium citrate) was administered subcutaneously (iron dose 120 Wmol/
kg). In some experiments animals received a double dose of iron (240
Wmol/kg). Control animals received LPS plus Na-citrate. At 6 h after
LPS, the mice received 2.2 mmol/kg DETC, they were killed 30 min
later and liver tissue obtained. Some animals treated with iron did not
receive DETC, they were killed at 6 h after LPS; blood samples
obtained from these animals were used for nitrosyl hemoglobin
(HbNO) measurement; sera were used for NO32 =NO
3
3 assay and liver
tissue was used to determine total amount of free iron by iron-desferal
EPR assay [14].
2.3. EPR measurements
EPR measurements were performed at 77 K with a Bruker ER 200
X-band spectrometer using an EPR ¢nger Dewar (Wilmad Class,
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Buena, NJ). DETC2-Fe-NO complexes were determined by EPR in
the liver tissue frozen in liquid nitrogen. Whole blood obtained from
mice without anticoagulant (0.5 ml sample volume) was frozen imme-
diately at 77 K for EPR detection of HbNO. Total amount of
DETC2-Fe complex formed in tissue by DETC was determined after
additional incubation of tissue with SIN-1 as described earlier [15].
Total amount of free iron was determined in the liver tissue homoge-
nate of mice untreated with DETC after additional incubation with
desferal as described [14,15].
2.4. Determination of iNOS protein by Western blot
Protein samples from the liver of control mice, LPS-treated mice,
and mice treated with LPS plus iron were homogenized and electro-
phoretically size-separated as we have previously described [16].
Equivalent amounts of total liver protein from individual mice (100
Wg) were loaded into adjacent lanes and separated using a discontin-
uous system consisting of an 8% polyacrylamide resolving gel and a
6% stacking gel on an 8U10 cm electrophoresis cell (Bio-Rad, Her-
cules, CA). Following separation, the proteins were electrophoretically
transferred to a nitrocellulose membrane which was blocked with 12%
non-fat dried milk in Tris-bu¡ered saline (NFM/TBS) for a minimum
of 2 h. The membranes were incubated with a 1:1000 dilution of
polyclonal rabbit anti-iNOS antibody in 4% NFM/TBS for 60 min
at room temperature. Membranes were then incubated with HRP-
labeled goat anti-rabbit IgG (1:1000) in 4% NFM/TBS for an addi-
tional 60 min at room temperature. Thorough rinsing of membranes
was performed between each step using three rinses of Tris-bu¡ered
saline with 0.8% Tween-20 for a minimum of 5 min each. The bound
antibody was detected with a chemiluminescent HRP substrate and
exposed to X-ray ¢lm (BIOMAX MR, Eastman Kodak, Rochester,
NY). The ¢lms were processed with a Kodak M35 X-OMAT auto-
processor (Eastman Kodak), and densitometry was performed using a
Phosphorimager Personal Densitometer (Molecular Dynamics, Sun-
nyvale, CA).
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Fig. 1. Top: Representative Western blot for iNOS protein in which
100 Wg of total liver protein from mice treated with vehicle control
(lanes 1 and 6), LPS (lanes 2 and 7), LPS plus 120 Wmol/kg iron
(lanes 3 and 8) and LPS plus 240 Wmol/kg iron (lanes 4 and 9) were
loaded. Lane 5 contains the size markers. Bottom: Densitometric
analysis of iNOS protein band in mice treated with vehicle control
(n = 6), LPS (n = 6), LPS plus 120 Wmol/kg iron (designated Fe Low,
n = 4), and LPS plus 240 Wmol/kg iron (designated Fe High, n = 4).
*P6 0.05 compared to LPS-treated mice.
Fig. 2. EPR spectra (77 K) obtained from the liver tissue of septic shock mice, which received 6 mg LPS i.v. and simultaneously s.c. injection
of Na-citrate (A) or citrate complex of iron: 120 Wmol/kg (B), 240 Wmol/kg (C) plus i.p. injection of DETC 2.2 mmol/kg (at 6 h after LPS ad-
ministration). Normal mice (D) received only DETC injection. All mice were killed 30 min after DETC injection, then liver tissue samples were
frozen at 77 K and EPR spectra recorded. The spectra show only triplet EPR signal of DETC2-Fe-NO complex at gP = 2.041. The receiver
gain for spectrum (D) was 10-fold higher than for other spectra. EPR conditions were: microwave frequency 9.40 GHz, microwave power 10
mW, modulation frequency 100 kHz, modulation amplitude 3.2 G, center ¢eld 3292 G, scan rate 42 G/min, time constant 0.5 s.
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2.5. Statistical analysis
Data are expressed as the mean þ standard error. Di¡erences be-
tween groups were evaluated with a one way analysis of variance
and a Tukey test. A probability level of P6 0.05 was considered
signi¢cant.
3. Results and discussion
Administration of endotoxin to mice induced iNOS protein
expression (Fig. 1) in the liver tissue of animals (iNOS protein
was not found in the normal tissue). We observed a concom-
itant increase in the nitric oxide level in liver tissue of LPS-
treated mice after administration of DETC, yielding DETC2-
Fe-NO complexes with a characteristic triplet EPR signal at
gP = 2.041 (Fig. 2) in tissues of mice (only a trace amount of
DETC2-Fe-NO complex observed in the liver of normal ani-
mals). The augmentation of NO level had a systemic character
judging from the increase in the amounts of NO32 =NO
3
3 (Ta-
ble 1) and nitrosyl hemoglobin (Fig. 3) in murine circulation.
HbNO in the whole blood of endotoxin-treated mice pro-
duced characteristic triplet EPR signal of nitrosyl heme
(aN = 17.5 G) centered at g = 2.012 (Fig. 3). Previously, we
have demonstrated that short-term (30 min) Fe exposure did
not a¡ect HbNO and NO32 =NO
3
3 levels in blood of septic
shock mice, when iron was given after iNOS expression (i.e.
at 6 h after LPS administration) [15]. In this study simulta-
neous administration of endotoxin (6 mg per animal, i.v.) and
iron (120 or 240 Wmol/kg, s.c.) produced signi¢cantly lower
iNOS protein expression in the liver (Fig. 1), decreased
NO32 =NO
3
3 level in sera (Table 1) and HbNO level in whole
blood 6 h later (Fig. 3), compared to LPS-treated animals.
Incidentally, the dose of iron administered to mice (120
Wmol/kg) is close to the amount of iron which mice consume
daily in the diet (33 mg/kg per day) [17]. The amount of free
iron in the murine liver tissue homogenate has been deter-
mined by EPR as [FeIII-desferal] complex, which produced a
broad EPR signal at g = 4.3. Free Fe in the liver rose about
two-fold after the iron dose of 120 Wmol/kg and more than
six-fold after the Fe dose of 240 Wmol/kg (Table 1). We have
demonstrated previously that DETC and desferal sample the
same pool of free iron in liver tissue [15]. Administration of
DETC in vivo in iron-treated mice produced increased
amounts of DETC-Fe complex in the liver tissue, compared
to untreated animals (data not shown). However, the amount
of DETC2-Fe-NO complex formed in liver of Fe-treated sep-
tic shock mice was only 39 þ 9% (n = 6, Fe dose 120 Wmol/kg)
and 11 þ 2% (n = 3, Fe dose 240 Wmol/kg), compared to endo-
toxin-treated mice (Fig. 2). DETC has been chosen in this
study because it binds free iron in tissue, while N-methyl-D-
glucamine dithiocarbamate (MGD) requires simultaneous ad-
ministration of exogenous Fe to produce MGD2-Fe-NO com-
plex in tissue (this additional iron injection would complicate
the interpretation of the experiment).
Iron administration after iNOS expression (i.e. at 6 h after
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Table 1
The e¡ect of Fe-citrate administration on NO32 =NO
3
3 level in sera of endotoxin-treated mice
a
Experimental group NO32  NO33 (WM) Free Fe (nmol/g of liver wet wt.)b
A. LPS, citratec 340 þ 20 (3) 75 þ 11 (4)
B. LPS, Fe (120 Wmol/kg) 155 þ 23 (3)** 161 þ 18 (4)*
C. LPS, Fe (240 Wmol/kg) 71 þ 11 (4)*** 572 þ 137(4)*
D. Normal mice 23 þ 7 (5)**** 110 þ 10 (4)
aMice received LPS E. coli i.v. via the tail vein (6 mg per animal), Fe-citrate was given simultaneously with LPS as s.c. injection. Mice were killed at
6 h after LPS injection. Control mice (group A) received LPS and sodium citrate (167 mg/kg).
bThe amount of free iron in liver tissue was determined by EPR in desferal-treated liver homogenate as described [14,15].
cThe data are presented as mean þ standard error (number of animals); *P6 0.02; **P6 0.005; ***P6 0.001; ****P6 0.0005 compared to group
A.
Fig. 3. EPR spectra (77 K) of whole blood (0.5 ml sample volume) obtained from normal mice (A) and mice which received 6 mg LPS i.v.
and simultaneously s.c. injection of Na-citrate (167 mg/kg) in saline (B) or s.c injection of citrate complex of iron: 120 Wmol/kg (C), 240 Wmol/
kg (D) in saline. The animals were killed at 6 h after LPS injection. EPR conditions were the same as described for Fig. 2 except: center ¢eld
3350 G, scan rate 49 G/min, modulation amplitude 5 G and the receiver gain was 8-fold higher. The triplet EPR signal (v) at g = 2.012 is that
of nitrosyl heme.
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LPS) did not a¡ect systemic NO level in LPS-treated mice
[15]. Therefore, in vivo iNOS activity is not likely to be af-
fected by iron administration in this experiment. In agreement
with the above described attenuation of nitric oxide level in
endotoxin-treated mice, we observed iron-dependent down-
regulation of iNOS protein expression in the liver tissue of
mice (Fig. 1).
Direct iron regulation of nuclear transcription for cytokine-
inducible NOS mRNA has been suggested in macrophages.
iNOS activity decreased by half in cells activated with inter-
feron Q plus LPS in the presence of 50 WM ferric iron [9].
However, in cultured rat aortic smooth muscle cells ferric
and ferrous ions (up to 400 WM) were without e¡ect on
iNOS mRNA expression [11]. In our experiment in vivo,
NO level decreased more than two-fold, when free Fe content
in liver tissue rose up to 86 þ 20 nmol/g wet weight (n = 4)
above the control level (Fe-citrate complex was given simulta-
neously with LPS). More distant e¡ects of iron treatment in
vivo should be considered as well. For example, in early stud-
ies, direct iron binding to LPS molecule has been suggested to
modulate LPS interaction with cells in vivo, thus attenuating
LPS toxicity in rabbits [2]. However, to achieve this e¡ect,
preincubation of LPS and Fe (6 h) in vitro was required
before injection [2]. In our study, LPS and iron were injected
separately via di¡erent routes. Iron is rapidly chelated by
transferrin in the circulation, thus limiting the possibility of
interaction between iron and LPS in vivo. In addition, Fe-
citrate binding with endotoxin should antagonize all the ac-
tions of LPS. This was not the case in our study (LPS pre-
serves its lethal e¡ect in mice treated with 120 Wmol/kg of Fe
plus LPS). Moreover, iron continues to exert its NO inhibi-
tory activity even when it is given after LPS, but before iNOS
expression (data not shown).
Others have pointed out prooxidant e¡ect of iron [18] and
direct nitric oxide scavenging by iron complexes [19]. Interest-
ingly, nitrosyl iron complexes exert much less prooxidant ac-
tivity in vitro [20] and in rat hepatocyte culture [21] than ‘free’
iron complexes in the absence of NO. Therefore, in tissues of
septic shock animals, the prooxidant e¡ect of free iron should
be signi¢cantly alleviated due to massive NO production
[15,22]. Bene¢cial e¡ects of iron [2] and iron complexes [23]
were reported in endotoxin-treated animals. Fe-citrate can
bind NO in vitro, as evidenced by weak EPR resonance sim-
ilar to that in a neutral solution of FeSO4 treated with NO
[24]. However, NO depletion in iron-treated septic shock mice
could not be explained simply as NO scavenging by iron com-
plexes. This explanation does not take into account down-
regulation of iNOS protein expression after iron administra-
tion. In addition, Fe-citrate injection does not change
NO32 =NO
3
3 and nitrosyl hemoglobin levels in blood of ani-
mals, when it is given after iNOS activation (i.e. at 6 h after
LPS) [15].
In conclusion, this study demonstrates that exogenous iron,
when it is given before iNOS induction, attenuates nitric oxide
production in vivo in endotoxin-treated mice via down-regu-
lation of iNOS expression.
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